Author:
Buchler Tomas,Bortlicek Zbynek,Poprach Alexandr,Pavlik Tomas,Veskrnova Veronika,Honzirkova Michaela,Zemanova Milada,Fiala Ondrej,Kubackova Katerina,Slaby Ondrej,Svoboda Marek,Vyzula Rostislav,Dusek Ladislav,Melichar Bohuslav
Reference24 articles.
1. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma;Motzer;J Clin Oncol,2002
2. Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database;Poprach;Med Oncol,2012
3. US Food and Drug Administration. Guidance for industry: clinical trial endpoints for the approval of cancer drugs and biologics. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory%20Information/Guidances/UCM071590.pdf.
4. European Agency for the Evaluation of Medicinal Products. Guideline on the evaluation of anticancer medicinal products in man. www.rsihata.com/updateguidance/emea/old/020595en.pdf.
5. Survival after complete surgical resection of multiple metastases from renal cell carcinoma;Boorjian;Cancer,2011